Donanemab

Donanemab Shows Significant Advance in Alzheimerā€™s Treatment

Donanemab Shows Significant Advance in Alzheimerā€™s Treatment

SG Tylor

Source – Eli Lilly The full data from Eli Lilly’s TRAILBLAZER-ALZ 2 trial of the amyloid drug donanemab has validated ...